Jun Hyeok Park

Jun Hyeok Park

Auto-generated profile, based on publicly available information

Jun Hyeok Park

Department of Chemistry, Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
BLBobin Lee
Bobin Lee
BPByungho Park
Byungho Park
DKDaeun Kim
Daeun Kim
CJChaewon Jung
Chaewon Jung
JPJun Hyeok Park
Jun Hyeok Park
KKKihyeun Kim
Kihyeun Kim
The lateral flow immunoassay (LFIA) is one of the most successful sensing platforms for real-world point-of-care (POC) testing. However, achieving PCR-level sensitivity without compromising the inherent advantages of LFIA, such as rapid and robust operation, affordability, and naked-eye detection, has remained a primary challenge. In this study, a plasmonic scattering-utilising LFIA was proposed, created by transparentising a nitrocellulose membrane and placing a light-absorbing backing card under the membrane. This LFIA minimised the background signal from its matrix, leading to substantially enhanced sensitivity and enabling naked-eye detection of the plasmonic scattering signal from gold nanoparticles without optics. Our plasmonic scattering-utilising LFIA showed an approximately 2600–4400 times higher detection limit compared with that of commercial LFIAs in influenza A assays. In addition, it exhibited 90% sensitivity in clinical validation, approaching PCR-level sensitivity, while commercial LFIAs showed 23–30% sensitivity. The plasmonic scattering-utilising LFIA plays a ground-breaking role in POC diagnostics and significantly boosts follow-up research.